Introduction
Hepatic AED results from infection by the larval forms of Echinococcus multilocularis. The echinococce almetacestode develops in the liver and is characterized by an alveolar structure, made up by several vesicles surrounded by large granulomas, which grows primarily in the liver of an infected person and develops as a cancer like lesion with slow growth. [1] [2] [3] [4] [5] Partial curative surgical resection in early stage and liver transplantation in advanced stage are accepted treatment options for AED. Many cases of AED are diagnosed at an advanced stage, hence curative partial liver resection can be performed in only 35% of patients 4 . Liver transplantation should be accepted as a lifesaving treatment option in patients with AED for whom there is no other medical or surgical treatment option 1 . It is commonly known that AED is characterized by strong adhesions and invasions to the adjacent structures. It complicates the operative technique and increases morbidity and sometimes may increase mortality. 6 .The only treatment option for advanced stage of AED with invasion to IVC is liver transplantation with replacement of IVC.
Here we present a patient, who underwent the living donor liver transplantation for hepatic AED with portal hypertension and chronic cholestasis. Strong adhesions to surrounding tissue, right diaphragm and invasion to the IVC forced us to perform resection liver with retrohepatic IVC and reconstruction of resected part of IVC with cryopreserved venous graeft. 
Case report
A 49 year old woman with abdominal ascites and edema of lower extremities due to advanced stage AED was transferred to our center. Levels of aspartate aminotransferase: 41 U/L, alanine aminotransferase: 38 U/L, alkaline phosphatase: 688 U/L, gammaglutamyl transpeptidase: 246 U/L, Total bilirubine: 0,88 mg/dl, direct bilirubine: 0,56 mg/dl, albumin: 2,3 g/dl, BUN: 32 mg/dl and creatinine: 1,59 mg/dl. International Normalized Ratio:1.9 and the model for end stage liver disease score was 11.2. At CT scan it was found a cystic lesion 17.3 × 12 × 15 cm in size without any contrast collecting during all phases, heterogenic and lobulated with calcification on one wall which fills liver segments V-VIII, and partially extending to segment II and III, (Fig. 1 ). Indirect echinococcal hemagglutination Bhemagglutination test was positive. Because of intrahepatic dissemination of the lesions and IVC compression was chosen as the method of definitive treatment. Mercedes incision was chosen for abdominal exploration. Large liver with alveolar disease and strong widespread adhesions with surrounding tissues, anterior abdominal wall, right hemidiaphragm and invasion to the retrohepatic part of IVC made recipient hepatectomy more difficult than other cirrhotic livers. Especially invasion to the IVC forces us to perform IVC resection with liver( Fig. 2a ), and replacement of resected part of IVC with cryopreserved caval greft ( Fig. 2b,2c ). We did not use veno-venous bypass during IVC reconstruction. A right lobe living related liver transplantation was done. The donor was her nephew. Graft/recipient weight ratios was more than 1% (680 gr/ 66 kg). Venous and arterial reconstructions were carried out with a standard method that was mentioned before. 6 Thus, we used cryopreserved vein grafts surrounding the hepatic veins for extension with 6.0 polypropylene sutures and to make allin-one orifice. This provided us an easier and large anastomosis with replaced IVC. Portal vein patch or extension is not required for end-to-end porto-portal anastomosis. Portal vein anastomosis was made with 6.0 polyprolene sutures. Arterial anastomosis was performed with x6.5 surgical loupes by separated 8.0 polyprolene sutures. Duct-to-duct biliary anastomosis was performed, an external drainage tube was placed from cystic ductus of recipient in to anastomosis. (Fig. 2d ). After 10 months follow up period, routine check-ups of the recipient and the donor were performed. Both of them didn't have any problem.
Discussion
Surgery is the first-choice option in all operable patients with AED of liver. Radical resection of the entire hepatic parasitic lesions is the only curative procedure, even though it is often difficult to achieve because of echinococcal dissemination into host tissues. Palliative liver surgery is not an ideal option, because it does not eliminate the disease and makes the secondary treatments more and more challenging. 7 Moreover, its own morbidity and mor- tality is not lower than expected. 5, 8 Buttenschoen et al. (2009) reported that palliative surgery was done in 58% of cases and curative resection only in 42%. In the palliative surgery group, morbidity was 19% and 28% died from AED 164-338 months after the first diagnosis (late lethality). The reasons for performing palliative surgery was sometimes the widespread location of the lesions in the liver but sometimes the reason may be the invasions of the major vascularities such as IVC. 8 Clinical findings and complications of multiple AED like chronic jaundice, liver abscess, sepsis, repeated attacks of cholangitis, portal hypertension, and Budd-Chiari syndrome may be an indication for liver transplantation. 9, 10 In our case AED invaded all parts of the liver and IVC. Large mass of AED compressing the portal vein and IVC caused portal hypertension and edema of low extremities, respectively. It was decided to be treated with liver transplantation. In 1994 Moreno et al reported five cases of OLT for AED. Two of them had secondary sclerosing cholangitis, two patient had biliary sclerosis and one patient had post necrotic liver cirrhosis. 3 Xia et al. (2005) also reported five cases orthotropic liver transplantatıon for AED. 11 Resection and reconstruction of IVC during for AED was reported by Moray et al. They reported two cases of liver transplantation for AED and one of them had operation with resection and replacement of IVC with polytetrafluoroethylene graft 1 . In our other experience, we also performed replacement of the IVC for living donor liver transplantation in Budd-Chiari syndrome associated with previous hydatid cyst (cystic echinococcosis) surgery. Retrohepatic part of IVC was replaced with a cadaveric aortic graft. 6 Matsuda H et al. (2010) presented two cases of hepatocellular carcinoma beyond the Milan criteria and they were underwent living-donor liver transplantation combined with aggressive hepatic IVC resection and replacement of the hepatic IVC by an artificial vascular graft. This procedure could be feasible and could prevent post-transplant recurrence in hepatocellular carcinoma beyond the Milan criteria. 12 Recently the resection and reconstruction of IVC during living donor liver transplantation was reported by Ueda J et al (2013) . They report on a rare case of surgical resection of an IVC leiomyosarcoma mimicking a hepatic tumor. 13 Most patient series including liver transplantation for AED are related with deceased donors. Koch et al. studied 45 patients at 16 transplant centers in Europe. According to their report, overall 5-year survival and disease-free rates were 71% and 58%, respectively. 10 The authors showed that the most important factor for recurrence and for choosing a treatment option was disease stage. In our case, the liver, the surrounding tissues and the IVC removed completely and IVC was replaced with a cryopreserved cadaveric caval vein graft.
Conclusion
Although, living donor liver transplantatıon with IVC replacement for AED with invasion to the IVC is very difficult operation, it is life -saving option for the patients with advanced stage AED.
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